As health equity becomes a strategic priority in 2026, plan sponsors must navigate emerging trends in benefit design, digital access, data-driven care, and social needs integration to build more inclusive and resilient health strategies.

Empowering better outcomes for patients with complex conditions through personalized, high-touch care and data-driven clinical support. Accredo Specialty Pharmacy partners with payers, providers, and pharmaceutical manufacturers to deliver cost-effective specialty therapies, improve adherence, and reduce waste across the healthcare system.

Women’s health is evolving rapidly, with new coverage mandates, rising demand for inclusive benefits, and growing attention to life-stage care. Learn more about the five key trends plan sponsors should watch for in 2026 to better support the health and well-being of women in the workforce.

Encouraging genomic testing is critical to identifying lung cancer patients who would benefit from targeted therapy.

As oncology care rapidly evolves, plan sponsors must navigate a landscape shaped by innovation, rising costs, and growing demands for equity.

The EncircleRx^SM portfolio is part of our GLP-1 Management Suite of Solutions that helps plan sponsors reduce costs and enhance outcomes. EncircleRx: Cardiodiabesity gives clients optionality and predictability in managing cardiodiabesity—obesity, diabetes and cardiovascular disease—with the first-ever GLP-1 financial guarantee from a PBM.